E. Barutta

Machine learning techniques for classification problems related to therapies in diabetes patients

E. Barutta, 2020 .

Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients.

G. Balogh, D. Mailo, E. Barutta, 2010, Experimental and therapeutic medicine.

BRCA1 polymorphism in breast cancer patients from Argentina

G. Balogh, E. Barutta, E. Alonso, 2014, Oncology letters.

Mutant p 53 protein in serum could be used as a molecular marker in human breast cancer

L. Shulman, G. Balogh, D. Mailo, 2006 .

Mutant p53 protein in serum could be used as a molecular marker in human breast cancer.

L. Shulman, G. Balogh, D. Mailo, 2006, International journal of oncology.